Clare A. Cruickshank

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Patient partnership in primary health care systems of the future: a structured priority setting exercise.

Patient partnership in primary health care systems of the future: a structured priority setting exercise.

Journal: Research involvement and engagement

Published: November 18, 2025

Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial.

Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial.

Journal: Lancet (London, England)

Published: November 13, 2025

Supportive Care Needs of Patients with Breast Cancer Who Self-Identify as Black: An Integrative Review.

Supportive Care Needs of Patients with Breast Cancer Who Self-Identify as Black: An Integrative Review.

Journal: Current oncology (Toronto, Ont.)

Published: September 15, 2025

Am I attached? A patient-partnered approach to creating infographics about attachment to primary care in Ontario, Canada.

Am I attached? A patient-partnered approach to creating infographics about attachment to primary care in Ontario, Canada.

Journal: Research involvement and engagement

Published: August 20, 2024

International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial.

International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial.

Journal: BJU international

Published: July 18, 2023

TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.

TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.

Journal: Clinical and translational radiation oncology

Published: October 17, 2022

PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation.

PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation.

Journal: Clinical and translational radiation oncology

Published: September 09, 2022

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).

Journal: European urology

Published: March 29, 2022

Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.

Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.

Journal: The Lancet. Oncology

Published: December 21, 2021

Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).

Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).

Journal: European urology oncology

Published: May 24, 2021

VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis.

VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis.

Journal: British journal of cancer

Published: February 25, 2021

PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018).

PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018).

Journal: Clinical and translational radiation oncology

Published: August 11, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026